Evaluation of Suspected Antibiotic Allergies

Author/s: 
Ruchi Singla, Megan C Elios, Andrew M Davis
Date Added: 
September 16, 2024
Journal/Publication: 
JAMA
Publisher: 
American Medical Association
Publication Date: 
September 11, 2024
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
10.1001/jama.2024.14143
PMID (1): 
39259567

RPR Commentary

RPR Commentary: A CPG for management of patients with a history of allergy to antibiotics. James W. Mold, MD, MPH

Abstract

Antibiotic-associated adverse drug reactions are often mild (eg, nausea or diarrhea) and typically occur 1 to 6 hours after drug exposure. IgE-mediated reactions cause urticaria, angioedema, bronchospasm, or, in severe cases, anaphylaxis. Cell-mediated delayed hypersensitivity can occur over days to weeks, most commonly as benign cutaneous morbilliform eruptions, although more severe manifestations, such as Stevens-Johnson syndrome, may occur.

The guideline provides evidence-based recommendations for evaluating possible drug allergy in nonsteroidal anti-inflammatory drugs, chemotherapies, immune checkpoint inhibitors, biologic agents, and excipients (inactive substances formulated with pharmaceuticals). This JAMA Clinical Guidelines Synopsis focuses on practice recommendations for antibiotic allergy evaluation.

Text Availability

Free full text